| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 06/16/2011 | CA2783731A1 Aminoacyl trna synthetases for modulating inflammation |
| 06/16/2011 | CA2783669A1 Compositions comprising zinc finger domains and uses therefor |
| 06/16/2011 | CA2783010A1 Method and composition to increase radiation-induced tumor therapeutic effects |
| 06/16/2011 | CA2782898A1 Novel cyclic peptides |
| 06/16/2011 | CA2782789A1 Inhibiting bacterial infection and biofilm formation |
| 06/16/2011 | CA2782624A1 Therapeutic use of protein-polymer conjugates |
| 06/16/2011 | CA2782622A1 Enzymatic wound debriding compositions with enhanced enzymatic activity |
| 06/16/2011 | CA2782397A1 Use of transferrin in treatment of beta-thalassemias |
| 06/16/2011 | CA2781883A1 Anti-microbial agent from paenibacillus sp. and methods and uses thereof |
| 06/15/2011 | EP2333074A1 Substances and methods for the treatment of lysosmal storage diseases |
| 06/15/2011 | EP2333069A2 Therapeutic uses of IL-17 homologous polypeptides |
| 06/15/2011 | EP2333065A1 Novel MHC class II restricted T cell epitopes from the cancer antigen, NY ESO-1 |
| 06/15/2011 | EP2333064A1 Nucleotide and protein sequences of Nogo genes and methods based thereon |
| 06/15/2011 | EP2333063A1 Inducible small interfering RNA (sirna) expression constructs for targeted gene silencing |
| 06/15/2011 | EP2333062A1 RNA-interference by single-stranded RNA molecules |
| 06/15/2011 | EP2333061A1 Delivery of dsRNA to arthropods |
| 06/15/2011 | EP2333060A2 HLA-binding peptides, DNA fragments encoding the same and recombinant vectors |
| 06/15/2011 | EP2333048A1 PDGF for use in inducing proliferation of a neural progenitor cell that differentiates into neurons and oligodendrocytes by not astrocytes |
| 06/15/2011 | EP2332993A1 Human monoclonal antibody to the human epidermal growth factor receptor |
| 06/15/2011 | EP2332978A1 Novel polypeptides involved in immune response |
| 06/15/2011 | EP2332977A2 ActRII receptor polypeptides |
| 06/15/2011 | EP2332976A1 Novel polypeptides involved in immune response |
| 06/15/2011 | EP2332975A1 Human proteins |
| 06/15/2011 | EP2332974A2 Osteoprotegerin |
| 06/15/2011 | EP2332973A2 Differential in tumour gene products and use of same |
| 06/15/2011 | EP2332971A1 Epitope analogs |
| 06/15/2011 | EP2332970A2 Mutated pseudomonas exotoxins with reduced antigenicity |
| 06/15/2011 | EP2332968A1 Stabilized alpha helical peptides derived from the BCL2-family for therapy. |
| 06/15/2011 | EP2332967A1 Stabilized alpha helical peptides derived from the BCL2-family for therapy. |
| 06/15/2011 | EP2332966A1 Nucleic acids and corresponding proteins entitled 191P4D12(b) useful in treatment and detection of cancer |
| 06/15/2011 | EP2332964A1 Apoptotically active peptides |
| 06/15/2011 | EP2332962A1 Cyclopenta[g]quinazoline compounds for use in the treatment of inflammatory or allergic conditions |
| 06/15/2011 | EP2332961A2 Novel immunogenic compositions for the prevention and treatment of meningococcal disease |
| 06/15/2011 | EP2332956A1 Antibody binding to PRO71238 |
| 06/15/2011 | EP2332955A2 Antisense modulation of acyl CoA cholesterol acyltransferase-2 expression |
| 06/15/2011 | EP2332952A1 Modified 2' and 3'-nucleoside prodrugs for treating flaviridae infections |
| 06/15/2011 | EP2332938A1 Viral inhibitors |
| 06/15/2011 | EP2332935A1 Inhibitors of serine proteases, particularly HCV NS3-NS4A protease |
| 06/15/2011 | EP2332582A1 ACE2 activation for treatment of heart, lung and kidney disease and hypertension |
| 06/15/2011 | EP2332578A1 Methods of treating central nervous system ischemic or hemorrhagic injury using anti alpha4 integrin antagonists |
| 06/15/2011 | EP2332576A1 Immunotherapy of B-cell malignancies using anti-CD22 antibody conjugates |
| 06/15/2011 | EP2332574A1 HCV NS3/4A Sequences |
| 06/15/2011 | EP2332573A1 Chimeric alphavirus replicon particles |
| 06/15/2011 | EP2332568A1 Collagenase for opening obstructed biological conduits |
| 06/15/2011 | EP2332567A1 Combination therapy for treating protein deficiency disorders |
| 06/15/2011 | EP2332566A1 IL-10 related peptides for wound healing |
| 06/15/2011 | EP2332565A1 Low dose methods for treating disorders in which TNFalpha activity is detrimental |
| 06/15/2011 | EP2332564A1 Matrix-free osteogenic devices, implants and methods thereof |
| 06/15/2011 | EP2332563A2 Use of BAFF to treat sepsis |
| 06/15/2011 | EP2332562A2 Therapeutic agents for the treatment of tuberculosis, especially pulmonary tuberculosis |
| 06/15/2011 | EP2332561A1 Blockade of T lymphocyte down-regulation associated with CTLA-4 signaling |
| 06/15/2011 | EP2332560A1 Use of a neurofilament peptide for the treatment of glioma |
| 06/15/2011 | EP2332559A1 Peptides for the treatment of pain |
| 06/15/2011 | EP2332553A1 Methods and compositions to treat myocardial conditions |
| 06/15/2011 | EP2332531A1 Apo2 ligand/TRAIL formulations |
| 06/15/2011 | EP2332512A1 Method for enhancing effects of colorants and conditioners |
| 06/15/2011 | EP2332428A1 Nutritional Formulation comprising a cow's milk peptide-containing hydrolysate and/or peptides derived thereof for tolerance induction |
| 06/15/2011 | EP2332408A1 Treating neurological disorders |
| 06/15/2011 | EP2331687A2 Antimicrobial agents |
| 06/15/2011 | EP2331569A1 Recombinantly produced human factor viii and ix |
| 06/15/2011 | EP2331567A1 Peptidomimetic macrocycles |
| 06/15/2011 | EP2331564A2 Methods of treating inflammation |
| 06/15/2011 | EP2331562A2 Peptides presenting an epitope of an a domain of factor h binding protein and methods of use |
| 06/15/2011 | EP2331561A1 Libraries of peptide conjugates and methods for making them |
| 06/15/2011 | EP2331553A1 Hepatitis c virus inhibitors |
| 06/15/2011 | EP2331118A1 Composition of tumor-associated peptides and related anti-cancer vaccine for the treatment of glioblastoma (gbm) and other cancers |
| 06/15/2011 | EP2331116A1 Anti-infective compounds and uses thereof |
| 06/15/2011 | EP2331115A2 Purine nucleoside phosphorylase as enzymatic activator of nucleoside prodrugs |
| 06/15/2011 | EP2331114A2 Fc gamma receptor for the treatment of b cell mediated multiple sclerosis |
| 06/15/2011 | EP2331113A1 Complement inhibitors for treatment of injury form intracerebral hemorrhage |
| 06/15/2011 | EP2331112A1 Peptidic pth receptor agonists |
| 06/15/2011 | EP2331107A1 Vhz for diagnosis and treatment of cancers |
| 06/15/2011 | EP2331077A2 Stable forlulation comprising therapeutic polypeptides for oral administration |
| 06/15/2011 | EP2331048A1 Oligomeric biosurfactants in dermatocosmetic compositions |
| 06/15/2011 | EP2330920A1 High caloric enteral formulations |
| 06/15/2011 | EP2330897A1 Ngal-binding siderophores and use thereof to treat iron deficiency and iron overload |
| 06/15/2011 | EP2330896A1 Antinecrotic activity of alpha 1-antitrypsin |
| 06/15/2011 | EP2197479B1 Inositol pyrophosphates determine exocytotic capacity |
| 06/15/2011 | EP2117514B1 Compositions comprising peg- interferon alpha conjugates and raffinose as cryoprotectant |
| 06/15/2011 | EP1824881B1 Tgr3-like protein receptor |
| 06/15/2011 | EP1751189B1 Diagnostic and therapeutic applications of soluble lhcgr protein |
| 06/15/2011 | EP1642981B1 RECOMBINANT GENE MEDICINE OF ADENOVIRUS VECTOR AND GENE p53 FOR TREATING PROLIFERATIVE DISEASES |
| 06/15/2011 | EP1597585B1 Method for selecting a candidate drug compound |
| 06/15/2011 | EP1481061B1 Denaturant stable and/or protease resistant, chaperone-like oligomeric proteins, polynucleotides encoding same and their uses |
| 06/15/2011 | EP1455809B1 Inhibitors of hepatitis c virus |
| 06/15/2011 | EP1417229B1 Methods and compounds for the targeting of protein to exosomes |
| 06/15/2011 | EP1407267B1 Gel compositions |
| 06/15/2011 | EP1404710B1 Identification of ses-3 (spr-5) in c. elegans and the uses of the same |
| 06/15/2011 | EP0939804B2 NEUTROKINE alpha |
| 06/15/2011 | EP0805822B2 Spray dried erythropoietin |
| 06/15/2011 | CN201861992U Multiple coating mirco-capsulation lactic acid bacteria (MCM-LAB) structure |
| 06/15/2011 | CN1954883B Method for stabilizing hemoglobin oxygen carrier sample |
| 06/15/2011 | CN1820734B Treatment with anti-erbb2 antibodies |
| 06/15/2011 | CN1680432B Viral protein |
| 06/15/2011 | CN1543503B Metalloproteinase inhibitors for wound healing |
| 06/15/2011 | CN102099373A Multivalent fibronectin based scaffold domain proteins |
| 06/15/2011 | CN102099372A Anti-amyloid immunogenic compositions, methods and uses |
| 06/15/2011 | CN102099370A Anticancer compounds |
| 06/15/2011 | CN102099051A Use of pegylated type III interferons for the treatment of hepatitis c |
| 06/15/2011 | CN102099050A Orally administrable dosage forms comprising angiogenin and uses thereof |